Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Research

Remedy: Alan Wake 2 will be an impressive game

By Atte RiikolaAnalyst
12.06.2023, 07.54
Remedy Entertainment
Download report (PDF)

We believe that Remedy's current market cap of about EUR 350 million already prices good success for Alan Wake 2 to be released on October 17, 2023, and the other projects in the production pipeline are also expected to generate value. We are particularly confident in the success of the traditional AAA game projects under development, whereas the multiplayer projects Condor and especially Vanguard are the biggest question marks at this point. All in all, we consider Remedy’s equity story to be very interesting until the end of this decade, but the increased short-term valuation suggest you should press pause on your game controller in terms of additional purchases.

Remedy Entertainment

26.1EUR09.06.2023, 18.00
25EURTarget price
Reduce
Changed from:Accumulate
Recommendation updated:12.06.2023

Remedy Entertainment is a game developer. The business is primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games developed by the company include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and utility technology that powers many of the games. The company was founded in 1995 and has its headquarters in Espoo.

Read more on company page

Key Estimate Figures12.06.2023

202223e24e
202223e24e
Revenue43.636.260.6
growth-%-2.5 %-16.9 %67.4 %
EBIT (adj.)-0.6-12.25.8
EBIT-% (adj.)-1.3 %-33.6 %9.7 %
EPS (adj.)-0.13-0.910.34
Dividend0.100.100.10
Dividend %0.5 %0.7 %0.7 %
P/E (adj.)neg.neg.45.0
EV/EBITDA126.5neg.13.1
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.